LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 14

Search options

  1. Article ; Online: STAT-5 Regulates Transcription of the Topoisomerase IIβ-Binding Protein 1 (TopBP1) Gene To Activate the ATR Pathway and Promote Human Papillomavirus Replication.

    Hong, Shiyuan / Cheng, Shouqiang / Iovane, Andre / Laimins, Laimonis A

    mBio

    2015  Volume 6, Issue 6, Page(s) e02006–15

    Abstract: Unlabelled: The life cycle of high-risk human papillomaviruses (HPVs) is dependent upon epithelial differentiation. Following infection of basal cells, HPV genomes are stably maintained at low copy numbers, and productive replication or amplification is ...

    Abstract Unlabelled: The life cycle of high-risk human papillomaviruses (HPVs) is dependent upon epithelial differentiation. Following infection of basal cells, HPV genomes are stably maintained at low copy numbers, and productive replication or amplification is restricted to highly differentiated suprabasal cells. In high-risk HPV infections, the ATM pathway is constitutively activated in the absence of external DNA-damaging agents and is required for productive viral replication. The ataxia telangiectasia (ATM) pathway repairs double-strand breaks in DNA, while the ataxia telangiectasia and Rad3-related (ATR) pathway targets single-strand breaks. Our studies show that the ATR pathway, like the ATM pathway, is activated in HPV-positive cells and that inhibitors of ATR or CHK1 phosphorylation block both amplification and late viral gene expression in differentiated cells while moderately reducing stable copy numbers in undifferentiated cells. TopBP1 is a critical upstream activator of the ATR pathway and is expressed at elevated levels in HPV-positive cells. This increased expression of TopBP1 is necessary for ATR/CHK1 activation in HPV-positive cells, and knockdown blocks amplification. Furthermore, TopBP1 activation is shown to be regulated at the level of transcription initiation by the innate immune regulator STAT-5, which is activated by HPV proteins. STAT-5 has also been shown to be a regulator of the ATM response, demonstrating that these two pathways are coordinately regulated in HPV-positive cells. These findings identify a novel link between the innate immune response and activation of the ATR DNA damage response in regulating the life cycle of high-risk HPVs.
    Importance: High-risk human papillomaviruses (HPVs) are the causative agents of cervical and other anogenital cancers, as well as many oral cancers. HPVs infect epithelial cells and restrict productive viral replication or amplification and virion production to differentiated cells. Our studies demonstrate that HPVs activate the ATR single-strand DNA repair pathway and this activation is necessary for HPV genome amplification. The innate immune regulator STAT-5 is shown to regulate transcription of the ATR binding factor TopBP1, and this is critical for the induction of the ATR pathway. Our study identifies important links between innate immune signaling, the ATR DNA damage pathway, and productive HPV replication that may lead to the characterization of new targets for the development of therapeutics to treat HPV-induced infections.
    MeSH term(s) Ataxia Telangiectasia Mutated Proteins/metabolism ; Carrier Proteins/metabolism ; Cells, Cultured ; DNA-Binding Proteins/metabolism ; Gene Expression Regulation ; Gene Regulatory Networks ; Host-Pathogen Interactions ; Humans ; Keratinocytes/virology ; Nuclear Proteins/metabolism ; Papillomaviridae/physiology ; STAT5 Transcription Factor/metabolism ; Transcription, Genetic ; Viral Proteins/metabolism ; Virus Replication
    Chemical Substances Carrier Proteins ; DNA-Binding Proteins ; Nuclear Proteins ; STAT5 Transcription Factor ; TOPBP1 protein, human ; Viral Proteins ; ATM protein, human (EC 2.7.11.1) ; ATR protein, human (EC 2.7.11.1) ; Ataxia Telangiectasia Mutated Proteins (EC 2.7.11.1)
    Language English
    Publishing date 2015-12-22
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2557172-2
    ISSN 2150-7511 ; 2161-2129
    ISSN (online) 2150-7511
    ISSN 2161-2129
    DOI 10.1128/mBio.02006-15
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: MCMV Dissemination from Latently-Infected Allografts Following Transplantation into Pre-Tolerized Recipients.

    Shah, Sahil / DeBerge, Matthew / Iovane, Andre / Yan, Shixian / Qiu, Longhui / Wang, Jiao-Jing / Kanwar, Yashpal S / Hummel, Mary / Zhang, Zheng J / Abecassis, Michael M / Luo, Xunrong / Thorp, Edward B

    Pathogens (Basel, Switzerland)

    2020  Volume 9, Issue 8

    Abstract: Transplantation tolerance is achieved when recipients are unresponsive to donor alloantigen yet mobilize against third-party antigens, including virus. After transplantation, cytomegalovirus (CMV) reactivation in latently-infected transplants reduces ... ...

    Abstract Transplantation tolerance is achieved when recipients are unresponsive to donor alloantigen yet mobilize against third-party antigens, including virus. After transplantation, cytomegalovirus (CMV) reactivation in latently-infected transplants reduces allograft viability. To determine if pre-tolerized recipients are resistant to viral dissemination in this setting, we transfused chemically-fixed donor splenocytes (1-ethyl-3- (3'-dimethyl-aminopropyl)-carbo-diimide (ECDI)-treated splenocytes (ECDIsp)) to induce donor antigen tolerance without immunosuppression. In parallel, we implanted donor islet cells to validate operational tolerance. These pre-tolerized recipients were implanted with murine CMV (MCMV) latently-infected donor kidneys (a validated model of CMV latency) to monitor graft inflammation and viral dissemination. Our results indicate that tolerance to donor islets was sustained in recipients after implantation of donor kidneys. In addition, kidney allografts implanted after ECDIsp and islet implantation exhibited low levels of fibrosis and tubulitis. In contrast, kidney cellular and innate immune infiltrates trended higher in the CMV group and exhibited increased markers of CD8
    Keywords covid19
    Language English
    Publishing date 2020-07-26
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2695572-6
    ISSN 2076-0817
    ISSN 2076-0817
    DOI 10.3390/pathogens9080607
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Spindle cells from acquired immune deficiency syndrome-associated Kaposi's sarcoma lesions express telomerase activity directly relating to the RNA levels of fibroblast growth factor-2.

    Barillari, Giovanni / Franzese, Ornella / Iovane, André / Ensoli, Barbara

    International journal of cancer

    2010  Volume 127, Issue 10, Page(s) 2487–2489

    MeSH term(s) Acquired Immunodeficiency Syndrome/enzymology ; Acquired Immunodeficiency Syndrome/genetics ; Acquired Immunodeficiency Syndrome/pathology ; Fibroblast Growth Factor 2/biosynthesis ; Fibroblast Growth Factor 2/genetics ; Humans ; RNA, Neoplasm/biosynthesis ; RNA, Neoplasm/genetics ; RNA, Neoplasm/metabolism ; Sarcoma/enzymology ; Sarcoma/genetics ; Sarcoma/pathology ; Sarcoma, Kaposi/enzymology ; Sarcoma, Kaposi/genetics ; Sarcoma, Kaposi/pathology ; Sarcoma, Kaposi/virology ; Telomerase/metabolism
    Chemical Substances RNA, Neoplasm ; Fibroblast Growth Factor 2 (103107-01-3) ; Telomerase (EC 2.7.7.49)
    Language English
    Publishing date 2010-11-15
    Publishing country United States
    Document type Comment ; Letter ; Research Support, Non-U.S. Gov't
    ZDB-ID 218257-9
    ISSN 1097-0215 ; 0020-7136
    ISSN (online) 1097-0215
    ISSN 0020-7136
    DOI 10.1002/ijc.25268
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: A clinically relevant murine model unmasks a "two-hit" mechanism for reactivation and dissemination of cytomegalovirus after kidney transplant.

    Zhang, Zheng / Qiu, Longhui / Yan, Shixian / Wang, Jiao-Jing / Thomas, Paul M / Kandpal, Manoj / Zhao, Lihui / Iovane, Andre / Liu, Xue-Feng / Thorp, Edward B / Chen, Qing / Hummel, Mary / Kanwar, Yashpal S / Abecassis, Michael M

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

    2019  Volume 19, Issue 9, Page(s) 2421–2433

    Abstract: Reactivation of latent cytomegalovirus remains an important complication after transplant. Although immunosuppression (IS) has been implicated as a primary cause, we have previously shown that the implantation response of a kidney allograft can lead to ... ...

    Abstract Reactivation of latent cytomegalovirus remains an important complication after transplant. Although immunosuppression (IS) has been implicated as a primary cause, we have previously shown that the implantation response of a kidney allograft can lead to early transcriptional activation of latent murine cytomegalovirus (MCMV) genes in an immune-competent host and to MCMV reactivation and dissemination to other organs in a genetically immune-deficient recipient. We now describe a model that allows us to separately analyze the impact of the implantation effect vs that of a clinically relevant IS regimen. Treatment with IS of latently infected mice alone does not induce viral reactivation, but transplant of latently infected allogeneic kidneys combined with IS facilitates MCMV reactivation in the graft and dissemination to other organs. The IS regimen effectively dampens allo-immune inflammatory pathways and depletes recipient anti-MCMV but does not affect ischemia-reperfusion injury pathways. MCMV reactivation similar to that seen in allogeneic transplants combined with also occurs after syngeneic transplants. Thus, our data strongly suggest that while ischemia-reperfusion injury of the implanted graft is sufficient and necessary to initiate transcriptional reactivation of latent MCMV ("first hit"), IS is permissive to the first hit and facilitates dissemination to other organs ("second hit").
    MeSH term(s) Animals ; Cytomegalovirus Infections/complications ; Disease Models, Animal ; Gene Deletion ; Histones/metabolism ; Immunosuppression Therapy ; Kidney/pathology ; Kidney Transplantation/adverse effects ; Mice ; Mice, Inbred BALB C ; Muromegalovirus/physiology ; Phenotype ; Postoperative Complications/virology ; Proteomics ; Renal Insufficiency/complications ; Renal Insufficiency/surgery ; Reperfusion Injury ; Transplantation, Homologous ; Virus Activation
    Chemical Substances Histones
    Language English
    Publishing date 2019-05-14
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2060594-8
    ISSN 1600-6143 ; 1600-6135
    ISSN (online) 1600-6143
    ISSN 1600-6135
    DOI 10.1111/ajt.15376
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: A novel murine model of differentiation-mediated cytomegalovirus reactivation from latently infected bone marrow haematopoietic cells.

    Liu, Xue-Feng / Swaminathan, Suchitra / Yan, Shixian / Engelmann, Flora / Abbott, Darryl Adelaide / VanOsdol, Luke Andrew / Heald-Sargent, Taylor / Qiu, Longhui / Chen, Qing / Iovane, Andre / Zhang, Zheng / Abecassis, Michael M

    The Journal of general virology

    2019  Volume 100, Issue 12, Page(s) 1680–1694

    Abstract: CD34+ myeloid lineage progenitor cells are an important reservoir of latent human cytomegalovirus (HCMV), and differentiation to macrophages or dendritic cells (DCs) is known to cause reactivation of latent virus. Due to its species-specificity, murine ... ...

    Abstract CD34+ myeloid lineage progenitor cells are an important reservoir of latent human cytomegalovirus (HCMV), and differentiation to macrophages or dendritic cells (DCs) is known to cause reactivation of latent virus. Due to its species-specificity, murine models have been used to study mouse CMV (MCMV) latency and reactivation
    MeSH term(s) Animals ; Biomarkers ; Bone Marrow Cells/drug effects ; Bone Marrow Cells/metabolism ; Bone Marrow Cells/virology ; Cell Differentiation/drug effects ; Cells, Cultured ; Cytomegalovirus/physiology ; Cytomegalovirus Infections/virology ; Disease Models, Animal ; Female ; Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology ; Hematopoietic Stem Cells/metabolism ; Hematopoietic Stem Cells/virology ; Host-Pathogen Interactions ; Interleukin-4/pharmacology ; Kinetics ; Mice ; Myeloid Cells/drug effects ; Myeloid Cells/metabolism ; Myeloid Cells/virology ; Viral Tropism ; Virus Activation ; Virus Latency ; Virus Replication
    Chemical Substances Biomarkers ; Interleukin-4 (207137-56-2) ; Granulocyte-Macrophage Colony-Stimulating Factor (83869-56-1)
    Language English
    Publishing date 2019-10-24
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 219316-4
    ISSN 1465-2099 ; 0022-1317
    ISSN (online) 1465-2099
    ISSN 0022-1317
    DOI 10.1099/jgv.0.001327
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: MCMV Dissemination from Latently-Infected Allografts Following Transplantation into Pre-Tolerized Recipients

    Sahil Shah / Matthew DeBerge / Andre Iovane / Shixian Yan / Longhui Qiu / Jiao-Jing Wang / Yashpal S. Kanwar / Mary Hummel / Zheng J. Zhang / Michael M. Abecassis / Xunrong Luo / Edward B. Thorp

    Pathogens, Vol 9, Iss 607, p

    2020  Volume 607

    Abstract: Transplantation tolerance is achieved when recipients are unresponsive to donor alloantigen yet mobilize against third-party antigens, including virus. After transplantation, cytomegalovirus (CMV) reactivation in latently-infected transplants reduces ... ...

    Abstract Transplantation tolerance is achieved when recipients are unresponsive to donor alloantigen yet mobilize against third-party antigens, including virus. After transplantation, cytomegalovirus (CMV) reactivation in latently-infected transplants reduces allograft viability. To determine if pre-tolerized recipients are resistant to viral dissemination in this setting, we transfused chemically-fixed donor splenocytes (1-ethyl-3- (3′-dimethyl-aminopropyl)-carbo-diimide (ECDI)-treated splenocytes (ECDIsp)) to induce donor antigen tolerance without immunosuppression. In parallel, we implanted donor islet cells to validate operational tolerance. These pre-tolerized recipients were implanted with murine CMV (MCMV) latently-infected donor kidneys (a validated model of CMV latency) to monitor graft inflammation and viral dissemination. Our results indicate that tolerance to donor islets was sustained in recipients after implantation of donor kidneys. In addition, kidney allografts implanted after ECDIsp and islet implantation exhibited low levels of fibrosis and tubulitis. In contrast, kidney cellular and innate immune infiltrates trended higher in the CMV group and exhibited increased markers of CD8 + T cell activation. Tolerance induction was unable to prevent increases in MCMV-specific CD8 + T cells or dissemination of viral IE-1 DNA. Our data suggest that latently-infected allografts are inherently more susceptible to inflammation that is associated with viral dissemination in pre-tolerized recipients. Thus, CMV latently-infected allografts require enhanced strategies to protect allograft integrity and viral spread.
    Keywords transplant tolerance ; donor specific transfusion ; cytomegalovirus ; latency ; Medicine ; R
    Language English
    Publishing date 2020-07-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article: MCMV Dissemination from Latently-Infected Allografts Following Transplantation into Pre-Tolerized Recipients

    Shah, Sahil / DeBerge, Matthew / Iovane, Andre / Yan, Shixian / Qiu, Longhui / Wang, Jiao-Jing / Kanwar, Yashpal S / Hummel, Mary / Zhang, Zheng J / Abecassis, Michael M / Luo, Xunrong / Thorp, Edward B

    Pathogens. 2020 July 26, v. 9, no. 8

    2020  

    Abstract: Transplantation tolerance is achieved when recipients are unresponsive to donor alloantigen yet mobilize against third-party antigens, including virus. After transplantation, cytomegalovirus (CMV) reactivation in latently-infected transplants reduces ... ...

    Abstract Transplantation tolerance is achieved when recipients are unresponsive to donor alloantigen yet mobilize against third-party antigens, including virus. After transplantation, cytomegalovirus (CMV) reactivation in latently-infected transplants reduces allograft viability. To determine if pre-tolerized recipients are resistant to viral dissemination in this setting, we transfused chemically-fixed donor splenocytes (1-ethyl-3- (3′-dimethyl-aminopropyl)-carbo-diimide (ECDI)-treated splenocytes (ECDIsp)) to induce donor antigen tolerance without immunosuppression. In parallel, we implanted donor islet cells to validate operational tolerance. These pre-tolerized recipients were implanted with murine CMV (MCMV) latently-infected donor kidneys (a validated model of CMV latency) to monitor graft inflammation and viral dissemination. Our results indicate that tolerance to donor islets was sustained in recipients after implantation of donor kidneys. In addition, kidney allografts implanted after ECDIsp and islet implantation exhibited low levels of fibrosis and tubulitis. In contrast, kidney cellular and innate immune infiltrates trended higher in the CMV group and exhibited increased markers of CD8⁺ T cell activation. Tolerance induction was unable to prevent increases in MCMV-specific CD8⁺ T cells or dissemination of viral IE-1 DNA. Our data suggest that latently-infected allografts are inherently more susceptible to inflammation that is associated with viral dissemination in pre-tolerized recipients. Thus, CMV latently-infected allografts require enhanced strategies to protect allograft integrity and viral spread.
    Keywords Cytomegalovirus ; DNA ; T-lymphocytes ; allografting ; antigens ; fibrosis ; immunosuppression ; inflammation ; islets of Langerhans ; kidneys ; mice ; model validation ; pathogens ; splenocytes ; viability ; viruses
    Language English
    Dates of publication 2020-0726
    Publishing place Multidisciplinary Digital Publishing Institute
    Document type Article
    Note NAL-light
    ZDB-ID 2695572-6
    ISSN 2076-0817
    ISSN 2076-0817
    DOI 10.3390/pathogens9080607
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  8. Article: New insights in the genetics of isolated hypogonadotropic hypogonadism.

    Iovane, Andre / Aumas, Chantal / de Roux, Nicolas

    European journal of endocrinology

    2004  Volume 151 Suppl 3, Page(s) U83–8

    Abstract: Isolated gonadotropic deficiency or isolated hypogonadotropic hypogonadism is defined as a low sexual hormone secretion by the gonads associated with low LH and FSH plasma levels. Kallmann syndrome is defined as a congenital isolated gonadotropic ... ...

    Abstract Isolated gonadotropic deficiency or isolated hypogonadotropic hypogonadism is defined as a low sexual hormone secretion by the gonads associated with low LH and FSH plasma levels. Kallmann syndrome is defined as a congenital isolated gonadotropic deficiency associated with anosmia whereas the phenotype of the idiopathic form is limited to the gonadotropic axis. For several years, it has been known that mutations of the KAL-1 gene or loss-of-function mutations of GnRH receptor did not explain all familial cases of isolated gonadotropic deficiency with or without anosmia. Thus the existence of other genes playing a major role in the physiology of the gonadotropic axis was highly suggested. In 2003, fibroblast growth factor receptor 1 (FGFR1) and GPR54 were shown to be two of these genes. FGFR1 loss-of-function mutations were reported in Kallmann syndrome whereas inactivating mutations of GPR54 were described in the idiopathic form of the gonadotropic deficiency. These genetic studies have opened up a new chapter in the physiology and the pharmacology of the gonadotropic axis.
    MeSH term(s) Animals ; Chromosomes, Human, Pair 19 ; Disease Models, Animal ; Female ; Genetic Heterogeneity ; Gonadotropins/deficiency ; Humans ; Hypogonadism/genetics ; Kallmann Syndrome/genetics ; Male ; Mice ; Mutation ; Pedigree ; Receptor Protein-Tyrosine Kinases/genetics ; Receptor, Fibroblast Growth Factor, Type 1 ; Receptors, Fibroblast Growth Factor/genetics ; Receptors, G-Protein-Coupled ; Receptors, Kisspeptin-1 ; Receptors, Neuropeptide/genetics ; Telomere/genetics
    Chemical Substances Gonadotropins ; KISS1R protein, human ; Receptors, Fibroblast Growth Factor ; Receptors, G-Protein-Coupled ; Receptors, Kisspeptin-1 ; Receptors, Neuropeptide ; FGFR1 protein, human (EC 2.7.10.1) ; Fgfr1 protein, mouse (EC 2.7.10.1) ; Receptor Protein-Tyrosine Kinases (EC 2.7.10.1) ; Receptor, Fibroblast Growth Factor, Type 1 (EC 2.7.10.1)
    Language English
    Publishing date 2004-09-03
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 1183856-5
    ISSN 1479-683X ; 0804-4643
    ISSN (online) 1479-683X
    ISSN 0804-4643
    DOI 10.1530/eje.0.151u083
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Ritonavir or saquinavir impairs the invasion of cervical intraepithelial neoplasia cells via a reduction of MMP expression and activity.

    Barillari, Giovanni / Iovane, André / Bacigalupo, Ilaria / Palladino, Clelia / Bellino, Stefania / Leone, Patrizia / Monini, Paolo / Ensoli, Barbara

    AIDS (London, England)

    2012  Volume 26, Issue 8, Page(s) 909–919

    Abstract: Objective and design: Treatment of human immunodeficiency virus (HIV)-infected women with the highly active antiretroviral therapy (HAART) has reduced the onset of uterine cervical intraepithelial neoplasia (CIN), and halted its progression to cervical ... ...

    Abstract Objective and design: Treatment of human immunodeficiency virus (HIV)-infected women with the highly active antiretroviral therapy (HAART) has reduced the onset of uterine cervical intraepithelial neoplasia (CIN), and halted its progression to cervical carcinoma. We and others demonstrated that the HIV protease inhibitors (HIV-PIs) used in HAART can exert direct antitumour activities also in HIV-free preclinical or clinical models. As uterine cervical carcinoma is a leading cause of death in women independently of HIV infection, herein we assessed the impact of therapeutic concentrations of HIV-PIs including indinavir (IDV), saquinavir (SQV) or ritonavir (RTV) on cells obtained from CIN or cervical carcinoma lesions of HIV-negative women.
    Methods: HIV-PI effects were evaluated by cell invasion, growth or toxicity assays, and by RNA, protein or zymogram analyses.
    Results: Both SQV and RTV inhibited CIN cell invasion, and this was paralleled by a reduced expression and proteolytic activity of the matrix metalloproteinase (MMP)-2 and 9 in treated cells. SQV and RTV also reduced CIN cell growth rate, but did not affect the invasion or growth of cells derived from highly progressed cervical carcinoma.
    Conclusion: As MMP-2 and MMP-9 have a key role in CIN evolution into cervical carcinoma, these results support the use of SQV or RTV for the block of CIN clinical progression in either HIV-infected or uninfected patients.
    MeSH term(s) Cervical Intraepithelial Neoplasia/drug therapy ; Epithelial Cells/drug effects ; Female ; HIV Protease Inhibitors/pharmacology ; Humans ; Matrix Metalloproteinase 2/drug effects ; Matrix Metalloproteinase 2/metabolism ; Matrix Metalloproteinase 9/drug effects ; Matrix Metalloproteinase 9/metabolism ; Ritonavir/pharmacology ; Saquinavir/pharmacology ; Uterine Cervical Neoplasms/drug therapy
    Chemical Substances HIV Protease Inhibitors ; Matrix Metalloproteinase 2 (EC 3.4.24.24) ; Matrix Metalloproteinase 9 (EC 3.4.24.35) ; Saquinavir (L3JE09KZ2F) ; Ritonavir (O3J8G9O825)
    Language English
    Publishing date 2012-05-15
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 639076-6
    ISSN 1473-5571 ; 0269-9370 ; 1350-2840
    ISSN (online) 1473-5571
    ISSN 0269-9370 ; 1350-2840
    DOI 10.1097/QAD.0b013e328351f7a5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: The HIV protease inhibitor indinavir down-regulates the expression of the pro-angiogenic MT1-MMP by human endothelial cells.

    Barillari, Giovanni / Iovane, André / Bacigalupo, Ilaria / Labbaye, Catherine / Chiozzini, Chiara / Sernicola, Leonardo / Quaranta, Maria Teresa / Falchi, Mario / Sgadari, Cecilia / Ensoli, Barbara

    Angiogenesis

    2014  Volume 17, Issue 4, Page(s) 831–838

    Abstract: In addition to contrast human immunodeficiency virus (HIV) replication, the HIV protease inhibitors (HIV-PI) have reduced tumour incidence or clinical progression in infected patients. In this regard, we have previously shown that, independently of its ... ...

    Abstract In addition to contrast human immunodeficiency virus (HIV) replication, the HIV protease inhibitors (HIV-PI) have reduced tumour incidence or clinical progression in infected patients. In this regard, we have previously shown that, independently of its anti-viral activity, the HIV-PI indinavir (IDV) directly blocks matrix metalloproteinase (MMP)-2 proteolytic activation, thus efficiently inhibiting tumour angiogenesis in vitro, in animal models, and in humans. Herein we investigated the molecular mechanism for IDV anti-angiogenic effect. We found that treatment of human primary endothelial cells with therapeutic IDV concentrations decreases the expression of membrane type (MT)1-MMP, which is the major activator of MMP-2. This occurs for both the constitutive expression of MT1-MMP and that up-regulated by angiogenic factors. In either cases, reduction of MT1-MMP levels by IDV is preceded by the inhibition of the binding of the specificity protein (Sp)1 transcription factor to the promoter region of the MT1-MMP gene in endothelial cell nuclei. As MT1-MMP is key for tumour angiogenesis, these results support the use of IDV or its derivatives in anti-cancer therapy. This is recommended by the low toxicity of the drug, and the large body of data on its pharmacokinetic.
    MeSH term(s) Animals ; Cell Nucleus/metabolism ; Chromatin Immunoprecipitation ; Endothelial Cells/metabolism ; Fibroblast Growth Factor 2/metabolism ; Gene Expression Regulation, Enzymologic ; HIV Protease Inhibitors/chemistry ; Human Umbilical Vein Endothelial Cells ; Humans ; Indinavir/pharmacology ; Matrix Metalloproteinase 14/metabolism ; Mice ; Mice, Nude ; Neovascularization, Pathologic ; Promoter Regions, Genetic ; Real-Time Polymerase Chain Reaction ; Sp1 Transcription Factor/metabolism ; Vascular Endothelial Growth Factor A/metabolism
    Chemical Substances HIV Protease Inhibitors ; Sp1 Transcription Factor ; Vascular Endothelial Growth Factor A ; Fibroblast Growth Factor 2 (103107-01-3) ; Indinavir (5W6YA9PKKH) ; MMP14 protein, human (EC 3.4.24.80) ; Matrix Metalloproteinase 14 (EC 3.4.24.80)
    Language English
    Publishing date 2014-10
    Publishing country Germany
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1484717-6
    ISSN 1573-7209 ; 0969-6970
    ISSN (online) 1573-7209
    ISSN 0969-6970
    DOI 10.1007/s10456-014-9430-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top